Diopsys
Helping eye care specialists detect dysfunction early, track disease progression, and tailor treatment for each patient.
Helping eye care specialists detect dysfunction early, track disease progression, and tailor treatment for each patient.
Diopsys is a health care and medical devices startup that aims to support eye care specialists in detecting dysfunction early, tracking disease progression, and tailoring treatment for each patient. Founded in 1998, the company provides eye care professionals with objective, functional information about the health of the vision system to aid in the early detection of vision disorders, and post-treatment tracking for enhanced patient management.
The startup recently received a significant boost with a $1.05M venture round investment on 17 October 2019. The investment underscores the potential of Diopsys and its innovative approach to revolutionizing vision care. With a focus on leveraging technology to improve patient outcomes, Diopsys presents a compelling opportunity for venture capitalists seeking to support advancements in the health care and medical devices industries.
As the company continues to make strides in its mission to provide valuable insights for eye care specialists, investors have the opportunity to contribute to the growth and success of a venture that is dedicated to enhancing the early detection and management of vision disorders. The recent investment demonstrates confidence in Diopsys' vision and capabilities, positioning the startup as a promising player in the evolving landscape of eye care technology.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $1.05M | - | 17 Oct 2019 |
No recent news or press coverage available for Diopsys.
We care about your data, and we'd love to use cookies make your experience better.
